Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shock waves vs needle lavage: which eases shoulder pain best?

NCT ID NCT06528756

Symptom relief Sponsor: Maimónides Biomedical Research Institute of Córdoba Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 22, 2026 · Updated 4 times

Summary

This study compared two procedures for treating painful calcium buildup in the shoulder: barbotage (a needle-guided washout) and shock wave therapy. Sixty-three adults aged 30–60 with chronic shoulder pain were randomly assigned to one treatment. Researchers tracked pain levels and shoulder function for six months to see which approach offered better relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
barbotage (ultrasound-guided needle lavage) and shock wave therapy
What this could lead to
If one treatment proves better, it could become the preferred option for relieving shoulder pain and improving function in people with calcific tendinopathy.
What could go wrong
This is a small, completed trial with only 63 participants. Results may not apply to everyone, and neither treatment may show a clear advantage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

63 people

The number who actually took part.

Started

Jan 2024

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Patients aged 30 - 60 years. * Omoalgia lasting more than 3 months. * Radiographic and ultrasound visualization in both planes of calcification. * Sizes \> 5 millimeters (mm). Exclusion criteria: * Patients who do not meet inclusion criteria. * Presence of another obvious cause of pain (joint degeneration, capsulitis, rotator cuff tendon tears...) * Previously received barbotage or shock waves. * Contraindication of therapies: infection, allergies to medications, cancer...

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Barbotage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

calcific tendinitis disease of the tendon Shoulder Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Barbotage Calcific tendinitis High-energy shock waves Pain, shoulder Tendinopathy rotator cuff

Contacts and locations

Locations

  • Hospital Universitario Reina Sofia

    Córdoba, Córdoba, 14004, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.